The 8th Steering Committee Meeting of A-TANGO will take place remotely (via Zoom) on Wednesday, 25th September 2024 (14:00-17:15 h CET) to receive an update on each work package's progress and the next steps to get the clinical trial rolling. The project has faced and overcome many severe and unforeseeable hurdles until now. Therefore, we are happy to finally be on track to start the clinical "G-TAK trial" in several liver centers in the United Kingdom, aiming to help critically ill patients who suffer from alcoholic hepatitis and ACLF. During the Steering Committee (SC) Meeting, we also look forward to welcoming our new contract research organisation (CRO)!

In this collaborative presentation of A-TANGO's first major early-career scientists' (ECS) poster, Annarein Kerbert, a medical doctor (MD, PhD) at Leiden University Medical Center (LUMC, Netherlands), and Julian Pohl, a medical doctor (MD) at the Charité in Berlin (Germany), reveal the different clinical profiles of patients with alcohol-related hepatitis and acute-on-chronic liver failure (ACLF) versus infection-induced ACLF. The poster was presented at the annual congress of the European Association for the Study of the Liver (EASL Congress) in Milan, Italy, on Thursday, 6 June 2024 (poster number: THU-057-YI). View the full video on YouTube.

On the final day of this year's EASL Congress in Milan Italy (Saturday, 8 June 2024), we met with A-TANGO early-career scientist (ECS) Julian Pohl, a medical doctor at the Charité - Universitätsmedizin Berlin, at his poster (Poster-ID: SAT-452) to hear about how the clinical burden of cirrhosis and acute-on-chronic liver failure (ACLF) has evolved and changed over the past years. The COVID-19 pandemic had particular effects on the hospitalisation rate of cirrhotic patients and the severity and mortality of the disease. Watch the full video on YouTube for more insights.